Analystreport

PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) was downgraded by analysts at Cowen Inc from an "outperform" rating to a "market perform" rating.

PhaseBio Pharmaceuticals, Inc.  (PHAS) 
Last phasebio pharmaceuticals, inc. earnings: 3/30 08:01 am Check Earnings Report